New Providence, NJ, United States of America

Edge Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 100.0



Forward Citations = 47

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal R Loch Macdonald (5 out of 6 patents)

silverMedal Brian A Leuthner (2 out of 2 patents)

bronzeMedal Parissa Heshmati (1 out of 3 patents)

4.  Gary Anthony Winchester (1 out of 5 patents)

5.  Kevin Burton (1 out of 9 patents)

6.  Cara R Davis (1 out of 2 patents)

7.  Angela R Stella (1 out of 2 patents)

8.  R Loch Macdonald (1 patent)

9.  Brian Leuthner (0 patent)

10.  Loch R Macdonald (0 patent)


5 patents:

Company Overview
Edge Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for the treatment of life-threatening neurological conditions. The company's lead product candidate, EG-1962, is a novel therapy designed to improve outcomes for patients with aneurysmal subarachnoid hemorrhage. Edge Therapeutics is dedicated to advancing the field of neurology and improving patient care through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#6 in New Providence, NJ

#1,898 in New Jersey

#51,666 in US

New Providence, NJ (US)
New Providence, NJ, United States of America
Forward Citations = 47

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Edge Therapeutics, Inc.. Retrieved from https://idiyas.com/company/edge-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…